Max Robotics — Global Service Robot Directory + US Certification

About

James G. Schwade is a pioneering radiation oncologist whose research has significantly advanced the field of robotic stereotactic radiosurgery, particularly in the treatment of lung cancer. His work has centered on the clinical application of CyberKnife technology — an image-guided robotic system — to deliver precise, high-dose radiation to pulmonary tumors with curative intent, offering a critical alternative for patients deemed medically inoperable. Schwade's most influential contribution, "CyberKnife Radiosurgery for Stage I Lung Cancer: Results at 36 Months" (2007), has garnered 86 citations and helped establish the efficacy of this approach for early-stage non-small cell lung cancer (NSCLC). His subsequent studies on lung metastases and extended follow-up outcomes further validated CyberKnife as a viable, minimally invasive treatment modality, collectively attracting over 200 citations across his core publications. His 2011 feasibility study exploring individualized higher-dose five-fraction regimens of 70–75 Gy reflects his ongoing commitment to optimizing therapeutic ratios and pushing the boundaries of dose escalation safely. Through rigorous retrospective and prospective analyses, Schwade has helped shape modern stereotactic body radiotherapy protocols, providing the oncology community with evidence-based guidance for treating both primary and metastatic lung tumors with precision and efficacy.